8-K/A

FORM 8K/A AMENDED CURRENT REPORT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: June 26, 2017
Period of Report: June 12, 2017
Accession Number: 0001078782-17-000908

View Document ↗ View on SEC.gov ↗